2013
DOI: 10.1016/j.mric.2013.04.012
|View full text |Cite
|
Sign up to set email alerts
|

Breast MR Imaging for Extent of Disease Assessment in Patients with Newly Diagnosed Breast Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0
1

Year Published

2014
2014
2018
2018

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 21 publications
(19 citation statements)
references
References 91 publications
0
18
0
1
Order By: Relevance
“…Early successes with diagnostic applications of breast MR imaging such as axillary adenopathy with unknown primary, defining extent of disease for presurgical planning, and evaluation of treatment response were reported in the latter part of the 1990s and early 2000s (94-102). Currently, MR imaging for preoperative evaluation of disease extent in newly diagnosed breast cancer is controversial because studies have not clearly shown benefits in terms of reoperation rate, disease recurrence, or survival (103)(104)(105). Monitoring of treatment response to neoadjuvant chemotherapy is an accepted indication for breast MR imaging, as studies have shown clinical utility for predicting recurrence-free survival and pathologic complete response (Fig 13) (103,(106)(107)(108)(109).…”
Section: Breast Mr Imagingmentioning
confidence: 99%
“…Early successes with diagnostic applications of breast MR imaging such as axillary adenopathy with unknown primary, defining extent of disease for presurgical planning, and evaluation of treatment response were reported in the latter part of the 1990s and early 2000s (94-102). Currently, MR imaging for preoperative evaluation of disease extent in newly diagnosed breast cancer is controversial because studies have not clearly shown benefits in terms of reoperation rate, disease recurrence, or survival (103)(104)(105). Monitoring of treatment response to neoadjuvant chemotherapy is an accepted indication for breast MR imaging, as studies have shown clinical utility for predicting recurrence-free survival and pathologic complete response (Fig 13) (103,(106)(107)(108)(109).…”
Section: Breast Mr Imagingmentioning
confidence: 99%
“…Because MRI has been reported to cause an unfavorable increase in mastectomy rates [22], the lack of improved patient outcomes makes it difficult to justify the use of routine preoperative staging MRI for all patients [27][28][29]. However, it is possible that certain subsets of patients with breast cancer may benefit from preoperative MRI [30], including those with ILC, very young patients, those with genetic mutations, patients with axillary nodal metastases but unknown primary lesion, or patients being considered for partial breast irradiation.…”
Section: Lane Et Almentioning
confidence: 99%
“…Breast MRI is an imaging modality used in complement to mammography and ultrasound for cancer diagnosis, staging, and gaining additional knowledge about the tumor biology (Brasic, Wisner, & Joe, 2013; Knuttel, Menezes, van den Bosch, Gilhuijs, & Peters, 2014; Sardanelli et al, 2004; Saslow et al, 2007). MR imaging of breasts also finds usage in screening in high risk patients (C.…”
Section: Introductionmentioning
confidence: 99%